General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 8.20
+0.05 (0.61%)
Nov 10, 2026, 1:54 PM CST
General Biologicals Market Cap
General Biologicals has a market cap or net worth of 580.49 million as of November 10, 2026. It is the 37,377th most valuable company in the world and the 2,210th biggest in Taiwan. Its market cap has decreased by 25.44% in one year.
Market Cap
580.49M
Enterprise Value
2.51B
Revenue
260.23M
Global Rank
Country Rank
#2,210 Taiwan
PE Ratio
1.07
ChartMarket Cap Chart
Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 580.49M, an increase of 77.53%. That is a compound annual growth rate of 2.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 552.18M | -29.35% |
| Dec 31, 2025 | 781.59M | -38.66% |
| Dec 31, 2024 | 1.27B | -21.11% |
| Dec 29, 2023 | 1.62B | 0.37% |
| Dec 30, 2022 | 1.61B | -22.70% |
| Dec 30, 2021 | 2.08B | -35.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.12B |
| Excelsior Biopharma | 1.11B |
| Prince Pharmaceutical | 971.78M |
| Anxo Pharmaceutical | 951.50M |
| DV Biomed | 881.44M |
| Mediera | 811.23M |
| Winston Medical Supply | 676.72M |
| Bioray Biotech | 435.72M |